Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent.
about
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsPleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase.Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterizationThe systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy.Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome.
P2860
Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@ast
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@en
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@nl
type
label
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@ast
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@en
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@nl
prefLabel
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@ast
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@en
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@nl
P2093
P2860
P356
P1433
P1476
Human recombinant truncated RN ...... tial cancer therapeutic agent.
@en
P2093
Betty Schwartz
Liron Nesiel-Nuttman
Oded Shoseyov
P2860
P304
11464-11478
P356
10.18632/ONCOTARGET.2562
P407
P577
2014-11-01T00:00:00Z